COVID-19 drugs: Regulators join forces on real-world evidence
Article written by Gary Finnegan Medicines regulators from around the world are collaborating closely on the use of real-world evidence in assessing COVID-19 treatments and vaccines.
Article written by Gary Finnegan Medicines regulators from around the world are collaborating closely on the use of real-world evidence in assessing COVID-19 treatments and vaccines.
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended eight medicines for approval at its June 2020 meeting.